Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    May 2022
  1. ROIG CA, Ferrer CS, Garcia JLR, Cordon JP, et al
    "Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease".
    Gastroenterol Hepatol. 2022 May 20. pii: S0210-5705(22)00156.
    PubMed     Abstract available


  2. ALGABA A, Romero S, Granja A, Garza D, et al
    Serological Response To Vaccines Against Sars-Cov-2 In Patients With Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2022 May 20. pii: S0210-5705(22)00154.
    PubMed     Abstract available


  3. LATRAS CORTES I, Sierra-Ausin M
    Tacrolimus plus ustekinumab in refractory ulcerative colitis.
    Gastroenterol Hepatol. 2022 May 13. pii: S0210-5705(22)00145.
    PubMed    


  4. MARIA SR, Jesus B, Luis FS, Lara A, et al
    Incidence, and natural history of inflammatory bowel disease in Castilla y Leon: prospective and multicenter epidemiological study.
    Gastroenterol Hepatol. 2022 May 12. pii: S0210-5705(22)00139.
    PubMed     Abstract available


  5. SURIA C, Bosca-Watts MM, Navarro P, Tosca J, et al
    Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives.
    Gastroenterol Hepatol. 2022;45:383-389.
    PubMed     Abstract available


  6. RAMOS L, Ramos-Rodriguez J, Barreda R, Gutierrez-Nicolas F, et al
    Adherence to subcutaneous biologic treatment for inflammatory bowel disease.
    Gastroenterol Hepatol. 2022;45:335-341.
    PubMed     Abstract available


    April 2022
  7. MERINO GALLEGO E, Gallardo Sanchez F
    Prevalence of extra-intestinal manifestations, risk factors and therapeutic risk factors and therapeutic management in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2022;45 Suppl 1:4-5.
    PubMed    


  8. MARQUES-CAMI M, Garcia-Guinon A, Garreta J, Volta T, et al
    A 61-year-old patient with Crohn's disease and severe postoperative recurrence responding to JAK inhibitor ruxolitinib for polycythemia vera treatment.
    Gastroenterol Hepatol. 2022;45 Suppl 1:16-17.
    PubMed    


  9. ESTEBANEZ FERRERO B, Ruiz Pardo J, Velasco Albendea FJ, Vidana Marquez E, et al
    Tuberculosis mimicking Crohn's disease and respiratory infection by COVID-19.
    Gastroenterol Hepatol. 2022;45 Suppl 1:13-15.
    PubMed    


    March 2022
  10. NUNEZ F P, Quera R, Bay C, Thomson P, et al
    Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Gastroenterol Hepatol. 2022;45:223-230.
    PubMed     Abstract available


  11. MINGUEZ SABATER A, Conde Amiel I, Ladron Abia P, Martinez Delgado S, et al
    Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
    Gastroenterol Hepatol. 2022;45:177-185.
    PubMed     Abstract available


  12. MARIN-JIMENEZ I, Acosta MB, Esteve M, Castro-Laria L, et al
    Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
    Gastroenterol Hepatol. 2022;45:165-176.
    PubMed     Abstract available


    February 2022
  13. REFAIE E, Garcia Mateo S, Martinez Dominguez SJ, Gargallo-Puyuelo CJ, et al
    Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2022;45:114-122.
    PubMed     Abstract available


  14. ROCHA HC, Vilela EG
    Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Gastroenterol Hepatol. 2022;45:83-90.
    PubMed     Abstract available


    January 2022
  15. MEARIN F, Sans M, Balboa A
    Relevance and needs of Irritable Bowel Syndrome (IBS): comparison with Inflammatory Bowel Disease (IBD).
    Gastroenterol Hepatol. 2022 Jan 17. pii: S0210-5705(21)00332.
    PubMed     Abstract available


  16. YEBRA CARMONA J, Poza Cordon J, Suarez Ferrer C, Martin Arranz E, et al
    Correlation between endoscopy and intestinal ultrasound for the evaluation of postoperative recurrence of Crohn's disease.
    Gastroenterol Hepatol. 2022;45:40-46.
    PubMed     Abstract available


  17. ROJAS-FERIA M, Rodriguez-Fernandez M, Castro-Fernandez M, Suarez-Garcia E, et al
    Vedolizumab-induced cholestatic liver injury.
    Gastroenterol Hepatol. 2022;45:64-65.
    PubMed    


    December 2021
  18. ZAVALA-SOLARES MR, Salazar-Salas L, Yamamoto-Furusho JK
    Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2021;44:711-718.
    PubMed     Abstract available


    November 2021
  19. ZHANG X, Ma L, Zhang C, Hou B, et al
    Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p.
    Gastroenterol Hepatol. 2021;44:644-653.
    PubMed     Abstract available


    October 2021
  20. CALVET X, Carpio D, Rodriguez-Lago I, Garcia-Vicuna R, et al
    Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies.
    Gastroenterol Hepatol. 2021;44:587-598.
    PubMed     Abstract available


    August 2021
  21. FERREIRO-IGLESIAS R, Hernandez-Camba A, Serrano Labajos R, Rodriguez-Lago I, et al
    SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project.
    Gastroenterol Hepatol. 2021 Aug 25. pii: S0210-5705(21)00246.
    PubMed     Abstract available


  22. LIDON RV, Lopez SG, Roche PC, Miguel Boudet Barraca J, et al
    Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient s perspective: IBD-control, EII-control.
    Gastroenterol Hepatol. 2021 Aug 21. pii: S0210-5705(21)00243.
    PubMed     Abstract available


  23. RODRIGUEZ-LAGO I, Mesonero F, Hijos-Mallada G, Canas M, et al
    SELF-MEDICATION WITH ANALGESICS REPORTED BY PATIENTS WITH ULCERATIVE COLITIS: AN ANONYMOUS SURVEY.
    Gastroenterol Hepatol. 2021 Aug 13. pii: S0210-5705(21)00227.
    PubMed     Abstract available


  24. GENE M, Alguersuari A, Pons F, Minambres C, et al
    Serrated epithelial lesion with dysplasia as a precursor to small bowel carcinoma associated with Crohn's disease.
    Gastroenterol Hepatol. 2021;44:489-490.
    PubMed    


    July 2021
  25. LORAS C, Manosa M, Andujar X, Sanchiz V, et al
    Recommendations of the spanish group on crohn's disease and ulcerative colitis (geteccu) on the treatment of strictures in crohn's disease.
    Gastroenterol Hepatol. 2021 Jul 15. pii: S0210-5705(21)00219.
    PubMed     Abstract available


    June 2021
  26. HIJOS-MALLADA G, Sostres C, Gomollon F
    NSAIDs, gastrointestinal toxicity and Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2021 Jun 19. pii: S0210-5705(21)00201.
    PubMed     Abstract available


  27. FORTUNY BAUZA M, Canete Pizarro F, Calm Salvans A, Calafat Sard M, et al
    Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab.
    Gastroenterol Hepatol. 2021 Jun 9. pii: S0210-5705(21)00188.
    PubMed    


  28. GONZALEZ-MUNOZA C, Briones J, Sang Park H, Garcia-Planella E, et al
    Marginal zone lymphoma under anti-TNF treatment in Crohn disease.
    Gastroenterol Hepatol. 2021 Jun 9. pii: S0210-5705(21)00193.
    PubMed    


  29. JULIAO-BANOS F, Arrubla M, Osorio L, Camargo J, et al
    Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Gastroenterol Hepatol. 2021;44:398-404.
    PubMed     Abstract available


    May 2021
  30. PEREZ DE ARCE E, Quera R, Beltran CJ, Madrid AM, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis?
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00143.
    PubMed     Abstract available


  31. SEMPERE L, Bernabeu P, Cameo J, Gutierrez A, et al
    Evolution of the emotional impact in patients with early Inflammatory Bowel Disease during and after Covid-19 lockdown.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00145.
    PubMed    


    April 2021
  32. GONZALEZ AE, Castillejo ON, Sainz IF, Lopez-Garcia A, et al
    Use of capsule endoscopy in Inflammatory Bowel Disease in clinical practice in Spain. Results from a national survey.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00110.
    PubMed     Abstract available


  33. NUNEZ F P, Quera R, Sepulveda E, Simian D, et al
    Pregnancy in Inflammatory Bowel Disease: Experience of a Chilean cohort.
    Gastroenterol Hepatol. 2021;44:277-285.
    PubMed     Abstract available


  34. DIAZ ALCAZAR MDM, Martin-Lagos Maldonado A, Garcia-Consuegra Ruiz-Aragon FM, Herrera Mercader MDC, et al
    Liver abscesses as an initial manifestation of Crohn's disease.
    Gastroenterol Hepatol. 2021;44:310-311.
    PubMed    


  35. DE LOS MOZOS RUANO A, Casas Deza D, Calvo Galindo R, Solana Hidalgo MP, et al
    Methotrexate pneumonitis in a patient with Crohn's disease, during the COVID pandemic: An unusual clinical case and review of the literature.
    Gastroenterol Hepatol. 2021;44:302-303.
    PubMed    


  36. HALLOUCH TOUTOUH S, Lazaro Saez M, Hernandez Martinez A
    Ustekinumab for prevention of postoperative recurrence: Our clinical experience.
    Gastroenterol Hepatol. 2021;44:296-297.
    PubMed    


    February 2021
  37. SICILIA B, Vicente R, Arias L, Echarri A, et al
    Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis (Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients.
    Gastroenterol Hepatol. 2021 Feb 13. pii: S0210-5705(21)00043.
    PubMed     Abstract available


  38. CRISTINA SF, Angeles RRM, Maria SA, Luis RGJ, et al
    Nutricional Habits In Patients With Inflammatory Bowel Disease: Perception Of Patients And Health Professionals.
    Gastroenterol Hepatol. 2021 Feb 2. pii: S0210-5705(21)00014.
    PubMed    


  39. RODRIGUEZ C, Elosua A, Prieto C, Perez E, et al
    COLECTOMY RATE IN ULCERATIVE COLITIS 15 YEARS AFTER DIAGNOSIS: Results from the 2001-2003 Navarra cohort.
    Gastroenterol Hepatol. 2021 Feb 2. pii: S0210-5705(21)00003.
    PubMed     Abstract available


  40. PENNA FGC, Rosa RM, Pereira FH, Cunha PFS, et al
    Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease.
    Gastroenterol Hepatol. 2021;44:87-95.
    PubMed     Abstract available


    January 2021
  41. NAVARRO-CORREAL E, Borruel N, Robles V, de Guise CH, et al
    Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease.
    Gastroenterol Hepatol. 2021 Jan 27. pii: S0210-5705(21)00005.
    PubMed     Abstract available


  42. BLASCO PATINO F, Nicolae MV, Navarro E
    Acute submandibular sialadenitis in a patient with Crohn's disease being treated with infliximab.
    Gastroenterol Hepatol. 2021;44:49-50.
    PubMed    


    December 2020
  43. MUNOZ F, Ripolles T, Poza Cordon J, de Las Heras Paez de la Cadena B, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Dec 11. pii: S0210-5705(20)30214.
    PubMed     Abstract available


    November 2020
  44. RUBIANO MR, Medina GR, Perez-Riveros ED, Panqueva RDPL, et al
    Proctitis is not always ulcerative colitis.
    Gastroenterol Hepatol. 2020 Nov 25. pii: S0210-5705(20)30441.
    PubMed    


  45. QUERA R, Simian D, Flores L, Ibanez P, et al
    IMPACT OF THE COVID-19 PANDEMIC ON TREATMENT ADHERENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: EXPERIENCE OF A TERTIARY HOSPITAL IN CHILE.
    Gastroenterol Hepatol. 2020 Nov 21. pii: S0210-5705(20)30438.
    PubMed    


  46. QUERA R, Pizarro G, Simian D, Ibanez P, et al
    Impact of COVID-19 on a cohort of patients with inflammatory bowel disease at a specialised centre in Chile.
    Gastroenterol Hepatol. 2020 Nov 20. pii: S0210-5705(20)30431.
    PubMed    


  47. LADRON ABIA P, Alcala Vicente C, Martinez Delgado S, Bastida Paz G, et al
    Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis.
    Gastroenterol Hepatol. 2020 Nov 13. pii: S0210-5705(20)30364.
    PubMed    


  48. MINGUEZ SABATER A, Martinez Delgado S, Ladron Abia P, Bastida G, et al
    Skin injuries associated with biological therapy in inflammatory bowel disease: beyond psoriasis.
    Gastroenterol Hepatol. 2020 Nov 11. pii: S0210-5705(20)30378.
    PubMed    


  49. LUCAS RAMOS J, Suarez Ferrer C, Poza Cordon J, Sanchez Azofra M, et al
    Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Nov 7. pii: S0210-5705(20)30387.
    PubMed     Abstract available


  50. PEREZ DE ARCE E, Quera R, Nunez P, Simian D, et al
    Management of acute severe ulcerative colitis in chile: Experience of a multidisciplinary team.
    Gastroenterol Hepatol. 2020 Nov 6. pii: S0210-5705(20)30400.
    PubMed    


    October 2020
  51. QUERA R, Simian D, Nunez P, Flores L, et al
    Are patients with inflammatory bowel disease receiving adequate immunisation?
    Gastroenterol Hepatol. 2020 Oct 29. pii: S0210-5705(20)30303.
    PubMed     Abstract available


  52. EZQUERRA A, Resina E, Montes A, Alvarez-Male T, et al
    Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30377.
    PubMed    


  53. NUNEZ P, Garcia Mateo S, Quera R, Gomollon F, et al
    Inflammatory bowel disease and the risk of cardiovascular diseases.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30375.
    PubMed     Abstract available


  54. NUNEZ F P, Quera R, Simian D, Flores L, et al
    Infliximab in inflammatory bowel disease. Is premedication necessary?
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30362.
    PubMed     Abstract available


  55. NUNEZ F P, Mahadevan U, Quera R, Bay C, et al
    Treat-to-target approach in the management of inflammatory Bowel disease.
    Gastroenterol Hepatol. 2020 Oct 15. pii: S0210-5705(20)30318.
    PubMed     Abstract available


  56. LOPEZ GONZALEZ J, Hernandez Martinez A, Lazaro Saez M, Vega Saenz JL, et al
    Experience with tofacitinib in patients with refractary ulcerative colitis.
    Gastroenterol Hepatol. 2020 Oct 10. pii: S0210-5705(20)30309.
    PubMed    


  57. GARCIA-ALANIS M, Quiroz-Casian L, Castaneda-Gonzalez H, Arguelles-Castro P, et al
    Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Oct 8. pii: S0210-5705(20)30304.
    PubMed     Abstract available


  58. DEL HOYO J, Aguas M
    Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
    Gastroenterol Hepatol. 2020;43:415-417.
    PubMed    


    August 2020
  59. MORENO MORALEDA I, Lazaro Saez M, Dieguez Castillo C, Hernandez Martinez A, et al
    Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
    Gastroenterol Hepatol. 2020 Aug 31. pii: S0210-5705(20)30245.
    PubMed    


  60. MORENO MORALEDA I, Lazaro Saez M, Dieguez Castillo C, Hernandez Martinez A, et al
    Immunotherapy-induced colitis: Could it be ulcerative colitis?
    Gastroenterol Hepatol. 2020 Aug 29. pii: S0210-5705(20)30243.
    PubMed    


  61. LOPEZ-SANROMAN A, Esplugues JV, Domenech E
    Pharmacology and safety of tofacitinib in ulcerative colitis.
    Gastroenterol Hepatol. 2020 Aug 20. pii: S0210-5705(20)30236.
    PubMed     Abstract available


  62. RIESTRA S, Taxonera C, Zabana Y, Carpio D, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Aug 19. pii: S0210-5705(20)30217.
    PubMed     Abstract available


  63. MARIN-JIMENEZ I, Gomollon F
    Year 1983: Smoking decreases the risk of ulcerative colitis.
    Gastroenterol Hepatol. 2020;43:373-374.
    PubMed    


  64. MARIN-JIMENEZ I, Gomollon F
    Year 2005: Clinical, serological and molecular classification of inflammatory bowel disease.
    Gastroenterol Hepatol. 2020;43:383-384.
    PubMed    


  65. SICILIA B, Garcia-Lopez S, Gonzalez-Lama Y, Zabana Y, et al
    GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach.
    Gastroenterol Hepatol. 2020;43 Suppl 1:1-57.
    PubMed     Abstract available


    July 2020
  66. ZHOU G, Xiong F, Yang X, Wang P, et al
    A case report of drug-induced ischemic colitis accompanied by ulcerative colitis.
    Gastroenterol Hepatol. 2020 Jul 24. pii: S0210-5705(20)30170.
    PubMed    


  67. ELORZA A, Rodriguez-Lago I, Martinez P, Hidalgo A, et al
    Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Jul 21. pii: S0210-5705(20)30238.
    PubMed     Abstract available


  68. ZABANA Y, Panes J, Nos P, Gomollon F, et al
    The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30165.
    PubMed     Abstract available


  69. MERINO GALLEGO E, Gomez Torres K, Martinez Amate E
    Debut Of Inflammatory Bowel Disease Associated To Ixekizumab In Patient With Moderate, Difficult -To-Manage Psoriasis.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30229.
    PubMed    


    June 2020
  70. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Rodriguez-Lago I, Guarner F, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
    Gastroenterol Hepatol. 2020 Jun 26. pii: S0210-5705(20)30160.
    PubMed     Abstract available


  71. MARIN-JIMENEZ I, Gomollon F
    History of inflammatory bowel disease on eleven infographics.
    Gastroenterol Hepatol. 2020 Jun 24. pii: S0210-5705(20)30166.
    PubMed    


  72. FERNANDEZ-DE LA VARGA M, Del Pozo-Del Valle P, Bejar-Serrano S, Garrido-Marin A, et al
    Secukinumab-induced ulcerative colitis: opening Pandora's box of immunity.
    Gastroenterol Hepatol. 2020 Jun 17. pii: S0210-5705(20)30156.
    PubMed    


    May 2020
  73. MARIN-JIMENEZ I, Zabana Y, Rodriguez-Lago I, Marin L, et al
    [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)].
    Gastroenterol Hepatol. 2020 May 15. pii: S0210-5705(20)30138.
    PubMed     Abstract available


    April 2020
  74. RAMOS LOPEZ L, Hernandez Camba A, Rodriguez-Lago I, Carrillo Palau M, et al
    Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Apr 26. pii: S0210-5705(20)30111.
    PubMed     Abstract available


  75. GONZALEZ-LAMA Y, Sanz J, Bastida G, Campos J, et al
    Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis.
    Gastroenterol Hepatol. 2020 Apr 1. pii: S0210-5705(20)30072.
    PubMed     Abstract available


  76. POUS S, Frasson M, Jimenez R, Pamies J, et al
    Relevance of dynamic studies with magnetic resonance enterography in Crohn's disease.
    Gastroenterol Hepatol. 2020;43:179-187.
    PubMed     Abstract available


    March 2020
  77. CASAS DEZA D, Garcia Lopez S, Lafuente Blasco M, Vicente Lidon R, et al
    Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort.
    Gastroenterol Hepatol. 2020;43:126-132.
    PubMed     Abstract available


    January 2020
  78. CASANOVA MJ, Chaparro M, Gisbert JP
    Errors in the care of inflammatory bowel disease patients: "Errata" Study.
    Gastroenterol Hepatol. 2020 Jan 18. pii: S0210-5705(19)30260.
    PubMed     Abstract available


  79. ALONSO-ABREU I, Alarcon-Fernandez O, Carrillo-Palau M, Ramos-Lopez L, et al
    Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.
    Gastroenterol Hepatol. 2020 Jan 13. pii: S0210-5705(19)30263.
    PubMed     Abstract available


  80. GELY C, Marin L, Gordillo J, Manosa M, et al
    Impact of pain associated with the subcutaneous administration of adalimumab.
    Gastroenterol Hepatol. 2020;43:9-13.
    PubMed     Abstract available


    December 2019
  81. BOSCA MM, Alos R, Maroto N, Gisbert JP, et al
    Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.
    Gastroenterol Hepatol. 2019 Dec 20. pii: S0210-5705(19)30259.
    PubMed     Abstract available


  82. GINARD D, Marin-Jimenez I, Barreiro-de Acosta M, Ricart E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis.
    Gastroenterol Hepatol. 2019 Dec 12. pii: S0210-5705(19)30256.
    PubMed     Abstract available


    November 2019
  83. SHENTOVA R, Baycheva M, Hadjiiski P, Kofinova D, et al
    Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
    Gastroenterol Hepatol. 2019 Nov 13. pii: S0210-5705(19)30220.
    PubMed     Abstract available


    October 2019
  84. BERMEJO F, Algaba A, Bonillo D, Jimenez L, et al
    Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
    Gastroenterol Hepatol. 2019 Oct 21. pii: S0210-5705(19)30198.
    PubMed     Abstract available


  85. MURZI M, Gordillo J, Oblitas E, Soriano G, et al
    Spontaneous hepatic portal venous gas in a patient with ulcerative colitis. A case report and a review.
    Gastroenterol Hepatol. 2019 Oct 19. pii: S0210-5705(19)30199.
    PubMed    


  86. HINOJOSA DEL VAL J, Barreiro-de Acosta M
    Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab.
    Gastroenterol Hepatol. 2019 Oct 18. pii: S0210-5705(19)30202.
    PubMed     Abstract available


  87. BARREIRO-DE ACOSTA M, Gutierrez A, Rodriguez-Lago I, Espin E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
    Gastroenterol Hepatol. 2019 Oct 9. pii: S0210-5705(19)30195.
    PubMed     Abstract available


  88. CEBRIAN GARCIA A, Ruiz-Clavijo D, Irisarri Garde R, Gonzalez de la Higuera Carnicer B, et al
    Bronchiolitis obliterans organizing pneumonia in Crohn's disease.
    Gastroenterol Hepatol. 2019;42:496-497.
    PubMed    


    August 2019
  89. PENA-VELEZ R, Almanza-Miranda E, Zaragoza-Arevalo GR
    Crohn's disease in a girl with VACTERL association: Can mitochondrial dysfunction coexist?
    Gastroenterol Hepatol. 2019;42:435-436.
    PubMed    


    June 2019
  90. FERRER BRADLEY I, Maroto Arce N, Mora Escrig M, Hinojosa Del Val J, et al
    Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
    Gastroenterol Hepatol. 2019;42:387-388.
    PubMed    


    April 2019
  91. FRASER CG
    Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies.
    Gastroenterol Hepatol. 2019;42:263-270.
    PubMed     Abstract available


    March 2019
  92. NAVARRO B, Blazquez T, Herreras J, Iborra M, et al
    Acute myocardial infarction in a patient with a recent diagnosis of Crohn's disease.
    Gastroenterol Hepatol. 2019;42:183-184.
    PubMed    


  93. GONZALEZ-OLIVARES C, Palomera-Rico A, Romera-Pintor Blanca N, Sanchez-Aldehuelo R, et al
    Pneumatosis intestinalis in Crohn's disease.
    Gastroenterol Hepatol. 2019;42:181-183.
    PubMed    


    July 2018
  94. MIRANDA-BAUTISTA J, Menchen L
    Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: